0,903  0,003  Lipoxygenase inhibitor
0,901  0,002  Monophenol monooxygenase inhibitor
0,888  0,001  Melanin inhibitor
0,882  0,004  15-Lipoxygenase inhibitor
0,841  0,003  NOS2 expression inhibitor
0,821  0,003  Skin whitener
0,780  0,006  Chemopreventive
0,768  0,005  12-Lipoxygenase inhibitor
0,768  0,011  Antineoplastic (lung cancer)
0,764  0,015  Transcription factor NF kappa B inhibitor
0,762  0,021  Apoptosis agonist
0,741  0,015  Antineoplastic (breast cancer)
0,735  0,025  Antiinflammatory
0,713  0,010  Antihypercholesterolemic
0,705  0,004  Hypoxia-inducible factor 1 alpha inhibitor
0,682  0,006  Antioxidant
0,674  0,027  Caspase 9 stimulant
0,654  0,009  UGT1A9 substrate
0,637  0,006  CYP1A2 inhibitor
0,610  0,010  Caspase 3 stimulant
0,607  0,014  Radioprotector
0,601  0,008  Free radical scavenger
0,603  0,010  Cardioprotectant
0,595  0,012  Cardiovascular analeptic
0,586  0,013  Proliferative diseases treatment
0,585  0,012  AR expression inhibitor
0,589  0,019  Prostate cancer treatment
0,581  0,016  Sensitization
0,563  0,012  Antineoplastic (brain cancer)
0,551  0,015  Antiosteoporotic
0,550  0,019  Bone diseases treatment
0,543  0,018  Antineoplastic (cervical cancer)
0,550  0,031  Antileukemic
0,528  0,011  UGT1A6 substrate
0,516  0,006  Antineoplastic (squamous cell carcinoma)
0,525  0,015  Antineoplastic (glioma)
0,518  0,010  Antihypertriglyceridemic
0,501  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,513  0,019  Cytostatic
0,518  0,025  CYP2C19 substrate
0,508  0,015  Nitric oxide antagonist
0,497  0,005  Protein-tyrosine phosphatase inhibitor
0,525  0,034  Antibacterial
0,499  0,013  Superoxide dismutase inhibitor
0,512  0,034  Antineoplastic (colorectal cancer)
0,491  0,013  Vasodilator
0,518  0,042  TNF expression inhibitor
0,508  0,032  Antineoplastic (colon cancer)
0,505  0,032  Immunosuppressant
0,485  0,028  CYP2C19 inhibitor
0,464  0,009  UGT1A3 substrate
0,465  0,012  UGT1A1 substrate
0,486  0,034  Histamine release inhibitor
0,520  0,075  Alpha-glucosidase inhibitor
0,460  0,023  Antineoplastic (multiple myeloma)
0,464  0,033  Ulceration
0,453  0,027  NOS3 expression inhibitor
0,452  0,030  Antineoplastic (melanoma)
0,444  0,023  Antiprotozoal (Leishmania)
0,424  0,010  Antihypotensive
0,439  0,033  Hepatic disorders treatment
0,427  0,021  Antiparasitic
0,416  0,012  Antineoplastic (carcinoma)
0,418  0,019  Myocardial infarction treatment
0,427  0,030  ICAM1 expression inhibitor
0,432  0,038  Antineoplastic (ovarian cancer)
0,415  0,025  Antineoplastic (glioblastoma multiforme)
0,389  0,005  Heat shock protein 90 antagonist
0,381  0,004  Gastritis treatment
0,392  0,016  UGT1A4 substrate
0,404  0,034  Chemoprotective
0,388  0,022  UDP-glucuronosyltransferase substrate
0,370  0,006  5-Lipoxygenase inhibitor
0,392  0,029  Hypoglycemic
0,367  0,013  VCAM1 expression inhibitor
0,364  0,012  Lipid peroxidase inhibitor
0,413  0,061  Antipruritic, allergic
0,379  0,028  Antineoplastic (renal cancer)
0,352  0,004  Electron transport complex I inhibitor
0,360  0,018  Hepatoprotectant
0,347  0,006  Antihemorrhagic
0,376  0,037  Antineoplastic (non-small cell lung cancer)
0,353  0,022  Antihelmintic
0,330  0,003  Papain-like protease (SARS coronavirus) inhibitor
0,378  0,052  Antifungal
0,390  0,066  CYP2C9 substrate
0,344  0,022  P-glycoprotein inhibitor
0,409  0,090  Alzheimer's disease treatment
0,366  0,047  Antineoplastic (pancreatic cancer)
0,333  0,014  Genotoxic
0,318  0,005  Aromatase inhibitor
0,362  0,053  CYP2D6 substrate
0,357  0,054  Respiratory analeptic
0,319  0,016  Topoisomerase II inhibitor
0,341  0,046  UGT2B4 substrate
0,300  0,007  Antibacterial (Helicobacter pylori)
0,388  0,098  Cyclophilin D inhibitor
0,388  0,098  Antidiabetic
0,315  0,025  Non-steroidal antiinflammatory agent
0,349  0,062  Streptokinase A inhibitor
0,311  0,025  Antimutagenic
0,301  0,018  NOS3 expression enhancer
0,288  0,008  Topoisomerase II alpha inhibitor
0,332  0,058  Lipoprotein disorders treatment
0,318  0,046  Antiamyloidogenic
0,276  0,005  Postmenopausal disorders treatment
0,270  0,003  Ornithine decarboxylase inhibitor
0,300  0,034  Platelet adhesion inhibitor
0,331  0,066  Apoptosis antagonist
0,325  0,061  Spasmolytic
0,283  0,021  Amylase inhibitor
0,266  0,005  MAP kinase kinase 4 inhibitor
0,343  0,085  CYP2C9 inhibitor
0,298  0,044  Antiulcerative
0,310  0,063  Antineoplastic (osteosarcoma)
0,298  0,052  Cytotoxic
0,253  0,008  Beta glucuronidase inhibitor
0,267  0,025  MAO inhibitor
0,298  0,062  Antihypoxic
0,263  0,032  Neurotrophic factor enhancer
0,286  0,058  Antineoplastic (liver cancer)
0,260  0,032  CYP2B6 inhibitor
0,253  0,026  UGT2B15 substrate
0,276  0,050  Carcinogenic
0,243  0,021  Antidiarrheal
0,281  0,060  Antidiabetic symptomatic
0,229  0,011  Breast cancer-resistant protein inhibitor
0,226  0,011  Dementia treatment
0,322  0,108  Antiprotozoal
0,293  0,081  Antimycobacterial
0,221  0,011  Vascular dementia treatment
0,228  0,025  Antineoplastic (bone cancer)
0,285  0,085  Analeptic
0,253  0,053  Antineoplastic enhancer
0,240  0,047  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,198  0,006  Lipase inhibitor
0,284  0,094  Sodium/bile acid cotransporter inhibitor
0,287  0,098  Antithrombotic
0,257  0,072  Vascular (periferal) disease treatment
0,269  0,085  CYP1A2 substrate
0,198  0,015  Mediator release inhibitor
0,248  0,068  Hypolipemic
0,184  0,005  Ca(v)3.1 blocker
0,286  0,108  Antiprotozoal (Plasmodium)
0,195  0,017  Coagulant
0,202  0,026  Topoisomerase I inhibitor
0,206  0,032  UGT2B10 substrate
0,244  0,071  Antineoplastic (lymphocytic leukemia)
0,245  0,072  Antineoplastic (sarcoma)
0,201  0,029  MAO A inhibitor
0,243  0,072  Antiglaucomic
0,265  0,096  CTGF expression inhibitor
0,194  0,026  Cystathionine beta-synthase inhibitor
0,182  0,015  Estrogen antagonist
0,277  0,113  CYP3A4 substrate
0,189  0,026  MAO B inhibitor
0,203  0,041  Phospholipase A2 inhibitor
0,197  0,035  Cyclooxygenase 1 inhibitor
0,173  0,012  Estrogen receptor beta antagonist
0,200  0,039  UGT2B9 substrate
0,194  0,035  Acetylcholinesterase inhibitor
0,224  0,067  Amyloid beta aggregation inhibitor
0,194  0,039  Tubulin antagonist
0,182  0,028  Farnesoid X receptor antagonist
0,245  0,094  Antituberculosic
0,191  0,042  Arachidonic acid antagonist
0,197  0,051  Heat shock protein 90 alpha antagonist
0,164  0,019  Androgen antagonist
0,178  0,033  Cholesterol synthesis inhibitor
0,172  0,028  Beta amyloid protein antagonist
0,149  0,006  Neuraminidase inhibitor
0,195  0,053  Succinate dehydrogenase inhibitor
0,230  0,088  Antipyretic
0,191  0,051  Antiviral (Herpes)
0,244  0,106  GST M1-1 substrate
0,152  0,015  Antiviral (Coronavirus)
0,152  0,015  Antiviral (SARS coronavirus)
0,218  0,081  Antineoplastic (lymphoma)
0,164  0,028  Antineoplastic antibiotic
0,147  0,012  Estrogen receptor alpha antagonist
0,226  0,096  DNA damaging
0,167  0,039  Antifungal (Cryptococcus)
0,252  0,124  Cholesterol antagonist
0,135  0,012  Estrogen agonist
0,150  0,032  Mucolytic
0,165  0,049  Bone formation stimulant
0,185  0,069  LDLR expression enhancer
0,172  0,056  Interferon gamma antagonist
0,252  0,138  Antineoplastic (small cell lung cancer)
0,190  0,085  Insulin sensitizer
0,183  0,085  Abortion inducer
0,118  0,022  Bile acid receptor antagonist
0,135  0,042  Expectorant
0,100  0,008  Potassium channel Kv1.3 blocker
0,121  0,029  NAD(P)H dehydrogenase (quinone) inhibitor
0,168  0,076  UGT2B7 substrate
0,168  0,076  Dual specificity phosphatase inhibitor
0,119  0,029  Phosphodiesterase 4D inhibitor
0,133  0,044  TRPA1 agonist
0,103  0,015  Neuraminidase (influenza) inhibitor
0,195  0,108  RNA-directed DNA polymerase inhibitor
0,148  0,061  Neurotrophic factor
0,109  0,024  Na+ K+ transporting ATPase inhibitor
0,092  0,009  Transcription factor RelA inhibitor
0,189  0,108  Nitric-oxide synthase stimulant
0,125  0,045  Xanthine oxidase inhibitor
0,105  0,025  Peroxisome proliferator-activated receptor gamma agonist
0,104  0,024  HIV-1 integrase (3'-Processing) inhibitor
0,153  0,074  Cholinergic
0,099  0,022  Leukotriene antagonist
0,087  0,011  Ca(v)3.2 blocker
0,089  0,013  Leukotriene B4 antagonist
0,141  0,066  Alkaline phosphatase inhibitor
0,123  0,051  Chelator
0,099  0,027  Leukotriene synthesis inhibitor
0,144  0,072  Protein kinase stimulant
0,126  0,054  Microtubule formation inhibitor
0,101  0,030  Keratolytic
0,184  0,114  Aldehyde oxidase inhibitor
0,112  0,042  UGT2B11 substrate
0,109  0,039  SULT1E1 substrate
0,130  0,062  Antineoplastic (uterine cancer)
0,078  0,012  Glucose-6-phosphate translocase inhibitor
0,127  0,063  DNA polymerase I inhibitor
0,150  0,086  Mutagenic
0,140  0,077  SULT1A3 substrate
0,073  0,013  Cathepsin L2 inhibitor
0,168  0,111  Teratogen
0,070  0,014  Pregnane X receptor antagonist
0,155  0,099  Diabetic nephropathy treatment
0,101  0,046  Alpha 2d adrenoreceptor antagonist
0,076  0,021  Fatty acid synthase inhibitor
0,172  0,119  Aryl hydrocarbon receptor agonist
0,112  0,060  Choleretic
0,217  0,166  Vasodilator, coronary
0,134  0,084  Cyclooxygenase inhibitor
0,166  0,116  Pneumotoxic
0,199  0,153  5 Hydroxytryptamine uptake stimulant
0,260  0,215  5 Hydroxytryptamine release inhibitor
0,192  0,151  Tyrosine 3 hydroxylase inhibitor
0,109  0,068  SULT1A1 substrate
0,081  0,040  Phosphodiesterase VI inhibitor
0,045  0,005  Inosine monophosphate dehydrogenase 1 inhibitor
0,120  0,081  Antiacne
0,155  0,116  Embryotoxic
0,051  0,012  Retinoid X receptor antagonist
0,143  0,104  Antipruritic, non-allergic
0,052  0,014  Retinoid X alpha receptor agonist
0,080  0,043  CDC25A inhibitor
0,094  0,058  ABCA1 expression enhancer
0,076  0,041  HIV-1 integrase inhibitor
0,051  0,017  Retinoid X receptor agonist
0,070  0,036  HIV-1 integrase (Strand Transfer) inhibitor
0,118  0,086  NADPH oxidase inhibitor
0,048  0,016  Inosine monophosphate dehydrogenase inhibitor
0,042  0,012  Retinoid X alpha receptor antagonist
0,151  0,122  Angiogenesis stimulant
0,041  0,011  Leukotriene B4 receptor 1 antagonist
0,077  0,049  Antitreponemal
0,059  0,031  Alpha tubulin antagonist
0,147  0,119  Cardiodepressant
0,063  0,038  Beta tubulin antagonist
0,166  0,142  Immunostimulant
0,076  0,051  SULT1A2 substrate
0,098  0,073  HDL-cholesterol increasing
0,117  0,094  Vanilloid 1 agonist
0,110  0,086  Alcohol dehydrogenase substrate
0,037  0,014  Estrogen-related receptor beta antagonist
0,061  0,038  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,093  0,071  Sulfotransferase substrate
0,054  0,033  Vanilloid 2 antagonist
0,057  0,037  Acetyl-CoA transferase 2 inhibitor
0,055  0,035  Aldose reductase inhibitor
0,029  0,009  Leukotriene B4 receptor 2 antagonist
0,117  0,103  Psychosexual dysfunction treatment
0,069  0,057  Peroxisome proliferator-activated receptor gamma antagonist
0,106  0,094  Cyclooxygenase 3 inhibitor
0,138  0,127  Pyruvate kinase inhibitor
0,039  0,028  Retinoic acid alpha receptor agonist
0,093  0,083  UGT2B1 substrate
0,021  0,012  Inosine monophosphate dehydrogenase 2 inhibitor
0,127  0,119  Aldose reductase substrate
0,066  0,060  Antibiotic
0,173  0,167  Antidiabetic (type 2)
0,248  0,244  Antineoplastic (solid tumors)
0,028  0,024  Estrogen receptor beta agonist
0,018  0,017  Retinoic acid alpha receptor antagonist
0,085  0,084  Skin irritative effect

